Cyclacel Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
CYCC
CUSIP
23254L801
All holders as of
Q1 2025
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 23254L801 since 12/18/2024, newest first.

Filer % of Class Filed
Lazar David E. 13D/A Amendment 2 0% 8/8/2025
Event 8/5/2025
Lazar David E. 13D/A Amendment 1 8.2% 8/4/2025
Event 7/30/2025
Armistice Capital, LLC 13G/A Amendment 2
9.2% 5/15/2025
Event 3/31/2025
Doris Wong Sing Ee 13D 70.0% 3/4/2025
Event 2/26/2025
Lazar David E. 13D 15.8% 2/28/2025
Event 2/6/2025
Armistice Capital, LLC 13G/A Amendment 1
10.0% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 22 1.63 M $454 k
2024 Q4 19 704 k $264 k
2024 Q3 16 202 k $200 k
2024 Q2 18 229 k $371 k
2024 Q1 15 60.8 k $127 k
2023 Q4 16 94.0 k $250 k